Lv L, Wang FY, Ma XX, Li ZH, Huang SP, Shi ZH, Ji HJ, Bian LQ, Zhang BH, Chen T, Yin XL, Tang XD. Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study. World J Gastroenterol 2017; 23(30): 5589-5601 [PMID: 28852318 DOI: 10.3748/wjg.v23.i30.5589]
Corresponding Author of This Article
Xu-Dong Tang, Director, Department of Gastroenterology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, No. 1, Xiyuan Caochang, Beijing 100091, China. txdly@sina.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
1 Age 18-70 yr, Chinese reading and writing ability
2 Meeting the Rome III diagnostic criteria for PDS
3 Having the symptom of “spleen-deficiency and Qi-stagnation”, “spleen-deficiency and damp-obstruction”, “spleen-Yang deficiency”.
4 Signing the informed consent form
Exclusion criteria
1 Combined with GI ulcer, erosive gastritis, atrophic gastritis, severe dysplasia of gastric mucosa or suspicious malignant lesion
2 Having overlap syndrome combined with gastroesophageal reflux disease or irritable bowel syndrome
3 Having alarm symptoms (weight loss, black or tar stool, dysphagia, etc.)
4 Having serious structural disease (disease of heart, lung, liver or kidney) or mental illness
5 History of surgery related with the gastrointestinal tract, except for appendectomy more than six months ago
6 Taking drugs which may affect the gastrointestinal tract, such as nonsteroidal anti-inflammatory drugs and aspirin
7 Allergy to the experimental medication
8 Difficulties in attending the trial (paralysis, serious mental illness, dementia, renal diseases, stroke, coronary atherosclerotic heart diseases, diabetes or mental diseases, illiteracy, etc.)
9 Pregnant or breastfeeding
10 Refusing to sign the informed consent form
Table 4 Components of the Xiangsha Liujunzi granules
Scientific name
Part used
Proportion of ingredients (100%)
Astragalus mongholicus
Root
12
Codonopsis pilosula
Root
12
Rhizoma Atractylodis Macrocephalae
Rhizome
12
Poria cocos
Sclerotium
12
Fructus Aurantii
Fruit
12
Amomum villosum
Fruit
6.4
Ligusticum chuanxiong Hort
Sclerotium
9.6
Rhizoma corydalis
Rhizoma
9.6
Medicated Leaven
Fermentation products
12
Glycyrrhiza uralensis Fisch
Root
2.4
Table 5 Subject characteristics (n = 202) n (%)
Characteristic
Placebo group (n = 67)
CHM group (n = 135)
Gender
Female
86 (63.7)
43 (64.2)
Age
mean ± SD
43.89 ± 13.32
44.33 ± 12.41
20-29
12 (17.9)
21 (15.6)
30-39
18 (26.9)
28 (20.7)
40-49
8 (11.9)
31 (22.9)
50-59
17 (25.4)
28 (20.7)
60+
12 (17.9)
21 (15.6)
Level of education
Primary school
5 (7.5)
9 (6.7)
Junior school
6 (8.9)
22 (16.3)
Senior school
15 (22.4)
23 (17)
Degree or above
41 (61.2)
81 (60)
Table 6 Gastric emptying rates of proximal and distal stomach
Time
Placebo (n = 67)
CHM (n = 135)
t
P value
0 wk
GE rate of proximal stomach
30 min
32.85 ± 19.27
30.91 ± 16.67
0.653
0.515
60 min
49.26 ± 18.67
49.46 ± 17.74
-0.066
0.947
90 min
66.37 ± 14.63
63.72 ± 17.51
0.948
0.344
120 min
76.54 ± 13.97
75.39 ± 13.91
0.487
0.627
GE rate of distal stomach
30 min
15.68 ± 35.26
6.81 ± 37.61
1.576
0.117
60 min
32.49 ± 30.82
26.91 ± 33.36
1.124
0.263
90 min
49.26 ± 25.93
41.84 ± 33.59
1.555
0.122
120 min
61.61 ± 21.85
57.52 ± 27.02
1.053
0.294
4 wk
GE rate of proximal stomach
30 min
28.48 ± 13.13
36.31 ± 10.78
-4.195
0.000
60 min
47.21 ± 16.76
56.92 ± 10.27
-4.722
0.000
90 min
59.59 ± 17.71
72.92 ± 16.94
-6.919
0.000
120 min
71.47 ± 16.94
82.31 ± 7.35
-5.888
0.000
GE rate of distal stomach
30 min
7.03 ± 35.40
-24.34 ± 34.02
5.707
0.000
60 min
26.94 ± 31.39
40.83 ± 16.37
-3.871
0.000
90 min
50.06 ± 21.97
56.90 ± 15.35
-2.406
0.017
120 min
61.89 ± 15.26
67.66 ± 13.41
-2.578
0.011
Citation: Lv L, Wang FY, Ma XX, Li ZH, Huang SP, Shi ZH, Ji HJ, Bian LQ, Zhang BH, Chen T, Yin XL, Tang XD. Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study. World J Gastroenterol 2017; 23(30): 5589-5601